查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470568

肝病診斷市場：按診斷技術和最終用戶分類 - 全球預測 2024-2030

Liver Disease Diagnostics Market by Diagnosis Technique (Biopsy, Endoscopy, Imaging), End-user (Hospitals, Laboratories) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年肝病診斷市場規模為99.4億美元，預計2024年將達110.9億美元，2030年將達到230.5億美元，複合年成長率為12.76%。

肝病診斷市場包括專門用於檢測和監測各種肝病（如肝炎、肝硬化、肝癌和非酒精性脂肪肝）的所有技術、產品和服務。主要目標是促進肝臟相關疾病的早期發現、準確分期和有效管理。肝病盛行率不斷上升，人們的認知和預防方法不斷提高，以及各地區醫療基礎設施的改善，使得肝病診斷解決方案的採用成為必要。此外，政府對肝病監測和管理的努力和資助正在增加對肝病診斷的需求。然而，肝病診斷面臨挑戰，例如先進診斷測試成本高、肝病診斷標準不一致以及資源匱乏地區的獲取機會有限。此外，缺乏某些肝臟疾病的特異性生物標記以及與侵入性診斷程序相關的風險可能會阻礙生長。然而，主要參與者正在探索非侵入性成像技術和生物標記發現等尖端發展，以避免技術和安全併發症。此外，人工智慧和機器學習在診斷中的日益整合，有望提高準確性和預測分析能力，也開闢了新的成長途徑。個人化醫療和基因組學也越來越受到關注，為客製化診斷和治療方法提供了潛力。

主要市場統計
基準年[2023] 99.4億美元
預測年份 [2024] 110.9億美元
預測年份 [2030] 230.5億美元
複合年成長率（%） 12.76%

診斷技術：診斷肝臟疾病的影像方法不斷進步

肝臟切片檢查是取出一小部分肝組織並在顯微鏡下觀察的過程。切片檢查對於診斷某些血液檢查或影像學檢查無法檢測到的肝臟疾病以及確定肝損傷的程度非常重要。當需要分析C型肝炎等慢性疾病造成的肝損傷程度，或需要診斷原因不明的肝臟異常時，通常會建議進行切片檢查。用於肝臟診斷的內視鏡檢查通常是指稱為內視鏡逆行性造影的手術，用於檢查膽管。它可以識別與膽管阻塞和肝臟疾病相關的異常。當醫生懷疑有影響膽管的疾病或需要移除膽管結石時，通常會進行內視鏡檢查。診斷影像，包括超音波、電腦斷層掃描和磁振造影，可以提供肝臟的詳細影像，有助於診斷脂肪肝、腫瘤和肝硬化等疾病。診斷影像是一種第一線非侵入性診斷技術，通常在需要目視評估肝臟結構和檢測腫塊時使用。實驗室檢查可以透過分析血液樣本來幫助診斷肝病。常見的測試包括肝酵素測試，如丙氨酸轉氨酶（ALT）測試和天門冬胺基轉移酶（AST）測試、膽紅素測試、白蛋白測試、血液凝固檢查和病毒性肝炎測試。實驗室檢查通常是診斷肝病的第一步，用於常規篩檢、監測疾病進展和評估治療效果。

最終用戶在政府措施的支持下進行全球醫院擴張，以發展強大的醫療保健基礎設施

醫院是肝病診斷的重要最終使用者。醫院通常擁有先進的診斷設備，並配備專門的醫療保健專業人員。肝病患者通常需要立即進行綜合治療，而醫院通常能夠提供這些治療。這包括一系列診斷測試，如血液測試、影像和切片檢查，以確認肝炎、肝硬化和肝癌等診斷。醫院通常根據需求而受到高度青睞，因為它們能夠提供從診斷到治療的一體化服務，包括緊急醫療護理、手術和術後追蹤。診斷服務與治療的結合是病人選擇醫院診斷的一個令人信服的理由。實驗室，無論是獨立的還是附屬於診所的，都專門分析血液和組織樣本以檢測肝臟異常。與醫院相比，檢測設施位置便利，診斷檢測所需時間更短。該實驗室主要滿足診斷和監測肝病所需的常規篩檢和血液檢測的需要。

區域洞察

架構地區以美國和加拿大為中心，具有強大的醫療保健結構和對各種疾病有利的報銷政策，促進了肝病診斷的發展。非侵入性成像技術和生物標記識別領域的創新正在獲得大量投資和專利申請。美國肝臟基金會為改善肝臟健康所做的努力等措施反映了該領域的積極努力。歐盟（EU）根據其成員國的不同，擁有不同的醫療保健系統和經濟實力，因此消費者行為也多種多樣。然而，歐洲肝臟研究協會臨床實踐指南的採用是肝臟疾病診斷標準化的重要因素。不斷增加的研發支出和多邊合作（例如歐盟的地平線 2020 計畫）展現了該地區充滿活力的創新環境。在亞太地區，由於肝臟相關疾病的盛行率不斷增加、人們對肝臟健康的認知不斷提高，以及政府努力將醫療設施擴展到馬蘇，因此對肝臟疾病診斷的需求正在迅速增加。此外，亞太地區擴大採用數位醫療服務和解決方案，這可以為該行業提供新的成長途徑。

FPNV定位矩陣

FPNV定位矩陣對於評估肝病診斷市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對肝病診斷市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.肝病診斷市場的市場規模與預測是多少？

2.肝病診斷市場預測期內需要考慮投資的產品、細分市場、應用及領域有哪些？

3.肝病診斷市場的技術趨勢與法規結構是什麼？

4.肝病診斷市場主要廠商的市場佔有率是多少？

5.進入肝病診斷市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 急性和慢性肝病盛行率增加
      • 制定政府和非政府意識計劃
      • 消費者對微創診斷系統的趨勢
    • 抑制因素
      • 診斷設備高成本且缺乏熟練的專業人員
    • 機會
      • 診斷系統的技術進步
      • 改善經濟中的醫療保健服務
    • 任務
      • 與肝臟診斷系統相關的複雜性
  • 市場區隔分析
    • 診斷技術：改善肝臟疾病診斷影像方法的持續進展
    • 最終用戶：政府努力建立強大的醫療基礎設施，擴大了世界各地的醫院規模
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章依診斷技術分類的肝病診斷藥物市場

  • 切片檢查
  • 內視鏡檢查
  • 影像
  • 臨床檢查

第7章肝病診斷市場：依最終使用者分類

  • 醫院
  • 研究機構

第8章北美、南美洲肝病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區肝病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的肝病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • E-Spicics 開始在美國商業銷售肝臟內視鏡，並在美國開設子公司。
    • Stone Diagnostics 提供纖維母細胞肝病測試
    • 預測健康情報推出針對未確診肝病的工具

第12章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-B9334AD6C587

[194 Pages Report] The Liver Disease Diagnostics Market size was estimated at USD 9.94 billion in 2023 and expected to reach USD 11.09 billion in 2024, at a CAGR 12.76% to reach USD 23.05 billion by 2030.

The liver disease diagnostics market encompasses all technologies, products, and services dedicated to detecting and monitoring various liver conditions, including hepatitis, cirrhosis, liver cancer, and non-alcoholic fatty liver disease. The primary goal is to promote early detection, accurate staging, and effective management of liver-related diseases. The rising prevalence of liver diseases, increased awareness and preventive approaches, and improvements in healthcare infrastructure across various regions have necessitated the adoption of liver disease diagnostics solutions. Additionally, supportive government initiatives and funding for liver disease research and management accentuate the need for liver disease diagnostics. However, liver disease diagnostics faces challenges related to the high costs of advanced diagnostic tests, discrepancies in liver disease diagnostic standards, and limited accessibility in low-resource settings. Moreover, the lack of specific biomarkers for certain liver diseases and the risks associated with invasive diagnostic procedures can hinder growth. However, key players are exploring cutting-edge developments such as non-invasive imaging technologies and biomarker discovery to circumvent technical and safety complications. Furthermore, the increasing integration of AI and ML in diagnostics, which promises enhanced accuracy and predictive analytics, also opens up new avenues for growth. Personalized medicine and genomics are also gaining traction, offering the potential for tailored diagnostic and therapeutic approaches.

KEY MARKET STATISTICS
Base Year [2023] USD 9.94 billion
Estimated Year [2024] USD 11.09 billion
Forecast Year [2030] USD 23.05 billion
CAGR (%) 12.76%

Diagnosis Technique: Ongoing advances to improve imaging modalities for liver disease diagnosis

A liver biopsy is a process that involves the removal of a small section of liver tissue, which is then examined under a microscope. Biopsies can be crucial in diagnosing certain liver diseases that are not detectable through blood tests or imaging and in determining the degree of liver damage. Biopsies are often recommended when it is necessary to analyze the severity of liver damage in chronic conditions such as hepatitis C or to diagnose unexplained liver abnormalities. Endoscopy for liver diagnostics most often refers to a procedure known as endoscopic retrograde cholangiopancreatography, which is used to examine the bile ducts. It can identify blockages or abnormalities connected with liver diseases. Endoscopy is typically used when there is a suspicion of diseases that affect the bile ducts or when there's a need to extract bile duct stones. Imaging techniques include ultrasound, computed tomography scan, magnetic resonance imaging, and other modalities that provide detailed pictures of the liver and can help diagnose conditions like fatty liver, tumors, and cirrhosis. Imaging is the first line of non-invasive diagnostic techniques often used when there's a need for a visual assessment of the liver structure and detection of masses. Laboratory tests help in the diagnosis of liver diseases through the analysis of blood samples. Common tests include liver enzyme tests such as the alanine transaminase (ALT) test, aspartate aminotransferase (AST) test, bilirubin tests, albumin tests, clotting tests, and viral hepatitis tests. Laboratory tests are usually the first step in diagnosing liver disease and are used for routine screening, monitoring of disease progression, and evaluating treatment efficacy.

End-user: Expansion of hospitals across the world supported by government initiatives for developing robust healthcare infrastructure

Hospitals represent a significant end-user for liver disease diagnostics. They are typically equipped with advanced diagnostic equipment and staffed by specialized healthcare professionals. Patients with liver diseases often require immediate and comprehensive care, which hospitals are usually able to provide. This includes a series of diagnostic tests such as blood tests, imaging, and biopsies to confirm the diagnosis of conditions such as hepatitis, cirrhosis, or liver cancer. The need-based preference for hospitals is generally high due to their ability to offer a full spectrum of services from diagnosis to treatment, including emergency care, surgery, and post-operative follow-ups. The integration of diagnostic services with therapeutic care is a compelling reason for patients to choose hospital-based diagnostics. Laboratories, either standalone or those associated with clinics, specialize in the analysis of blood and tissue samples to detect liver abnormalities. Compared to hospitals, laboratories may offer more convenient locations and quicker processing times for diagnostic tests, which can result in faster results for patients and physicians. Laboratories primarily cater to the need for routine screening and blood work required for the diagnosis and monitoring of liver diseases.

Regional Insights

The Americas region, particularly the U.S. and Canada, is characterized by the presence of a robust healthcare architecture and favorable reimbursement policies for various disease conditions, thereby fuelling the growth in liver disease diagnostics. Innovations in non-invasive imaging techniques and bio-marker identification are areas where significant investments and patent applications are seen. Initiatives such as the American Liver Foundation's efforts to improve liver health reflect the sector's proactive approach. The European Union displays diverse consumer behavior due to varying healthcare systems and economic capabilities across member countries. However, the adoption of the European Association for the Study of the Liver Clinical Practice Guidelines is a key factor in standardizing liver disease diagnostics. Increased R&D expenditure and multinational collaborations, such as those within the EU Horizon 2020 program, showcase the dynamic environment of innovation in the region. APAC region shows a burgeoning need for liver disease diagnostics due to the growing prevalence of liver-related disorders, growing awareness about liver health, and government initiatives to expand healthcare facilities to marginalized communities. The adoption of digital healthcare services and solutions is also gaining traction in the APAC region, which could create new avenues of growth for the industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Liver Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Liver Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Liver Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Argon Medical Devices, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux SA, Boston Scientific Corporation, Cook Medical Incorporated, Epigenomics AG, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, Hepatiq, Inc., Hologic, Inc., Horiba, Ltd., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medtronic PLC, Merck & Co., Inc., Perspectum Ltd., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Ri.Mos. Srl, Siemens Healthineers AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Liver Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diagnosis Technique
    • Biopsy
    • Endoscopy
    • Imaging
    • Laboratory Tests
  • End-user
    • Hospitals
    • Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Liver Disease Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Liver Disease Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Liver Disease Diagnostics Market?

4. What is the market share of the leading vendors in the Liver Disease Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Liver Disease Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Prevalence of Acute and Chronic Liver Diseases
      • 5.1.1.2. Development of Government and Non-Government Awareness Programs
      • 5.1.1.3. Consumer Inclination Towards Minimally Invasive Diagnostic Systems
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Diagnostic Devices and Lack of Skilled Professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Diagnostic Systems
      • 5.1.3.2. Improving Healthcare Access in Economies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity Associated with Liver Diagnostic Systems
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diagnosis Technique: Ongoing advances to improve imaging modalities for liver disease diagnosis
    • 5.2.2. End-user: Expansion of hospitals across the world supported by government initiatives for developing robust healthcare infrastructure
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Liver Disease Diagnostics Market, by Diagnosis Technique

  • 6.1. Introduction
  • 6.2. Biopsy
  • 6.3. Endoscopy
  • 6.4. Imaging
  • 6.5. Laboratory Tests

7. Liver Disease Diagnostics Market, by End-user

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Laboratories

8. Americas Liver Disease Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Liver Disease Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Liver Disease Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. E-Scopics Announces Commercial Launch Of Hepatoscope in the Us And Opens its Subsidiary in the US
    • 11.3.2. Stone Diagnostics to Provide Fibronostics Liver Disease Test
    • 11.3.3. Predictive Health Intelligence Launches Tool For Undiagnosed Liver Disease

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. LIVER DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LIVER DISEASE DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVER DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM LIVER DISEASE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. LIVER DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. LIVER DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023